215 related articles for article (PubMed ID: 8808128)
1. Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum.
Concas A; Mascia MP; Cuccheddu T; Floris S; Mostallino MC; Perra C; Satta S; Biggio G
Pharmacol Biochem Behav; 1996 Feb; 53(2):249-55. PubMed ID: 8808128
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
Concas A; Santoro G; Mascia MP; Maciocco E; Dazzi L; Ongini E; Biggio G
J Pharmacol Exp Ther; 1993 Nov; 267(2):844-51. PubMed ID: 8246158
[TBL] [Abstract][Full Text] [Related]
3. 2-Chloro-N6-cyclopentyladenosine (CCPA), an adenosine A1 receptor agonist, suppresses ethanol withdrawal syndrome in rats.
Concas A; Cuccheddu T; Floris S; Mascia MP; Biggio G
Alcohol Alcohol; 1994 May; 29(3):261-4. PubMed ID: 7945566
[TBL] [Abstract][Full Text] [Related]
4. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
[TBL] [Abstract][Full Text] [Related]
5. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
[TBL] [Abstract][Full Text] [Related]
6. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
Monopoli A; Conti A; Dionisotti S; Casati C; Camaioni E; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
Rosati AM; Traversa U
Biochem Pharmacol; 1999 Aug; 58(4):623-32. PubMed ID: 10413299
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in the neurotoxic effects of adenosine A1 receptor antagonism during ethanol withdrawal: reversal with an A1 receptor agonist or an NMDA receptor antagonist.
Butler TR; Smith KJ; Self RL; Braden BB; Prendergast MA
Alcohol Clin Exp Res; 2008 Jul; 32(7):1260-70. PubMed ID: 18482156
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.
Finlayson K; Maemoto T; Butcher SP; Sharkey J; Olverman HJ
Acta Pharmacol Sin; 2003 Aug; 24(8):729-40. PubMed ID: 12904270
[TBL] [Abstract][Full Text] [Related]
11. Chronic exposure to adenosine receptor agonists and antagonists reciprocally regulates the A1 adenosine receptor-adenylyl cyclase system in cerebellar granule cells.
Hettinger-Smith BD; Leid M; Murray TF
J Neurochem; 1996 Nov; 67(5):1921-30. PubMed ID: 8863496
[TBL] [Abstract][Full Text] [Related]
12. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
Rivkees SA; Lasbury ME; Barbhaiya H
J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
[TBL] [Abstract][Full Text] [Related]
13. Myocardial adenosine A1-receptor sensitivity during juvenile and adult stages of maturation.
Sawmiller DR; Fenton RA; Dobson JG
Am J Physiol; 1998 Feb; 274(2):H627-35. PubMed ID: 9486267
[TBL] [Abstract][Full Text] [Related]
14. Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium.
Morey TE; Belardinelli L; Dennis DM
Br J Pharmacol; 1998 Apr; 123(7):1425-33. PubMed ID: 9579739
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective adenosine A1 and A2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain.
Nehlig A; Daval JL; Boyet S
Eur J Pharmacol; 1994 Jun; 258(1-2):57-66. PubMed ID: 7925600
[TBL] [Abstract][Full Text] [Related]
16. 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors.
Klotz KN; Lohse MJ; Schwabe U; Cristalli G; Vittori S; Grifantini M
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):679-83. PubMed ID: 2615857
[TBL] [Abstract][Full Text] [Related]
17. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.
De Sarro G; De Sarro A; Di Paola ED; Bertorelli R
Eur J Pharmacol; 1999 Apr; 371(2-3):137-45. PubMed ID: 10357250
[TBL] [Abstract][Full Text] [Related]
18. Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice.
Prediger RD; da Silva GE; Batista LC; Bittencourt AL; Takahashi RN
Neuropsychopharmacology; 2006 Oct; 31(10):2210-20. PubMed ID: 16407902
[TBL] [Abstract][Full Text] [Related]
19. Binding of an adenosine A1 receptor agonist and adenosine A1 receptor antagonist to sheep pineal membranes.
Falcón J; Privat K; Ravault JP
Eur J Pharmacol; 1997 Oct; 337(2-3):325-31. PubMed ID: 9430432
[TBL] [Abstract][Full Text] [Related]
20. Effects of repeated administration of selective adenosine A1 and A2A receptor agonists on pentylenetetrazole-induced convulsions in the rat.
Adami M; Bertorelli R; Ferri N; Foddi MC; Ongini E
Eur J Pharmacol; 1995 Dec; 294(2-3):383-9. PubMed ID: 8750698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
